Anti-telomerase immune response predicts disease progression in chronic lymphocytic leukemia
Human telomerase reverse transcriptase (hTERT) is broadly expressed in many cancers. High hTERT expression have been described in chronic lymphocytic leukemia (CLL). Here we investigated the relationship between anti-hTERT immunity and disease progression in 49 CLL patients. Anti-hTERT T cell respon...
Main Authors: | Claire Germain, Julie Garibal, Valérie Doppler, Fanny Baran-Marszak, Florence Cymbalista, Julien Caumartin, Pierre Langlade-Demoyen, Maria Wehbe, Thierry Huet |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | Clinical Immunology Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772613421000093 |
Similar Items
-
Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia
by: Francesco Forconi, et al.
Published: (2022-01-01) -
Characterization of real‐world treatment practices and outcomes among patients with chronic lymphocytic leukemia treated in a Finnish tertiary center
by: Juha Ranti, et al.
Published: (2022-02-01) -
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course
by: Francesco Angotzi, et al.
Published: (2024-03-01) -
The Traf2DNxBCL2-tg Mouse Model of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Recapitulates the Biased IGHV Gene Usage, Stereotypy, and Antigen-Specific HCDR3 Selection of Its Human Counterpart
by: Gema Perez-Chacon, et al.
Published: (2021-04-01) -
HELQ and EGR3 expression correlate with IGHV mutation status and prognosis in chronic lymphocytic leukemia
by: Chao Guo, et al.
Published: (2021-01-01)